The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial
Open accessAbstract
Objectives: The AspireAssist System (AspireAssist) is an endoscopic weight loss device that is comprised of an endoscopically placed percutaneous gastrostomy tube and an external device to facilitate drainage of about 30% of the calories consumed in a meal, in conjunction with lifestyle (diet and exercise) counseling. Methods: In this 52-week clinical trial, 207 participants with a body-mass index (BMI) of 35.0–55.0 kg/m2 were randomly assigned in a 2:1 ratio to treatment with AspireAssist plus Lifestyle Counseling (n=137; mean BMI was 42.2±5.1 kg/m2) or Lifestyle Counseling alone (n=70; mean BMI was 40.9±3.9 kg/m2). The co-primary end points were mean percent excess weight loss and the proportion of participants who achieved at least a 25% excess weight loss. Results: At 52 weeks, participants in the AspireAssist group, on a modified intent-to-treat basis, had lost a mean (±s.d.) of 31.5±26.7% of their excess body weight (12.1±9.6% total body weight), whereas those in the Lifestyle Counseling group had lost a mean of 9.8±15.5% of their excess body weight (3.5±6.0% total body weight) (P<0.001). A total of 58.6% of participants in the AspireAssist group and 15.3% of participants in the Lifestyle Counseling group lost at least 25% of their excess body weight (P<0.001). The most frequently reported adverse events were abdominal pain and discomfort in the perioperative period and peristomal granulation tissue and peristomal irritation in the postoperative period. Serious adverse events were reported in 3.6% of participants in the AspireAssist group. Conclusions: The AspireAssist System was associated with greater weight loss than Lifestyle Counseling alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-term persistence of hormonal adaptations to weight loss
Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105816 · Cited by 1,449
Multicenter, placebo-controlled trial of lorcaserin for weight management.
Smith, S. R., Weissman, N. J., Anderson, C. M., Sanchez, M., Chuang, E., Stubbe, S., Bays, H., & Shanahan, W. R. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909809 · Cited by 911
Development of a brief measure to assess quality of life in obesity
Kolotkin, R. L., Crosby, R. D., Kosloski, K. D., & Williams, G. R. (2001) · Obesity Research · doi:10.1038/oby.2001.13 · Cited by 641
AGA technical review on obesity
Klein, S., Wadden, T., & Sugerman, H. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35514 · Cited by 274
Cited by
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.025 · Cited by 608
Self-citationMechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0406 · Cited by 510
Self-citationMechanick, J. I., Apovian, C., Brethauer, S., Timothy Garvey, W., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah‐Pollack, R., Seger, J., et al. (2020) · Obesity · doi:10.1002/oby.22719 · Cited by 389
Self-citationCurrent treatments for obesity
Ruban, A., Stoenchev, K., Ashrafian, H., & Teare, J. (2019) · Clinical Medicine · doi:10.7861/clinmedicine.19-3-205 · Cited by 266
Efficacy and Safety of Endoscopic Sleeve Gastroplasty: A Systematic Review and Meta-Analysis
Hedjoudje, A., Abu Dayyeh, B. K., Cheskin, L. J., Adam, A., Neto, M. G., Badurdeen, D., Morales, J. G., Sartoretto, A., Nava, G. L., Vargas, E., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.08.022 · Cited by 266
Self-citationHorn, D. B., Almandoz, J. P., & Look, M. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2051366 · Cited by 114
Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome
Siamashvili, M., & Davis, S. N. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1933433 · Cited by 82
Nyström, M., Machytka, E., Norén, E., Testoni, P. A., Janssen, I., Turró Homedes, J., Espinos Perez, J. C., & Turro Arau, R. (2018) · Obesity Surgery · doi:10.1007/s11695-017-3096-5 · Cited by 73
Network meta‐analysis of the relative efficacy of bariatric surgeries for diabetes remission
Kodama, S., Fujihara, K., Horikawa, C., Harada, M., Ishiguro, H., Kaneko, M., Furukawa, K., Matsubayashi, Y., Matsunaga, S., Shimano, H., et al. (2018) · Obesity Reviews · doi:10.1111/obr.12751 · Cited by 42
Effect of Aspiration Therapy on Obesity-Related Comorbidities: Systematic Review and Meta-Analysis
Jirapinyo, P., de Moura, D. T. H., Horton, L. C., & Thompson, C. C. (2020) · Clinical Endoscopy · doi:10.5946/ce.2019.181 · Cited by 32
“1).(8-12) All studies were graded as high quality (JBI score of 7, NOS of 7, and JADAD scores of 3, 3, and 3).”
BackgroundSelf-citationEndoscopic therapies for patients with obesity: A systematic review and meta-analysis
Weitzner, Z. N., Phan, J., Begashaw, M. M., Mak, S. S., Booth, M. S., Shekelle, P. G., Maggard-Gibbons, M., & Girgis, M. D. (2023) · Surgical Endoscopy · doi:10.1007/s00464-023-10390-6 · Cited by 27
“Both RCTs comparing AspireAssist to lifestyle modification demonstrated statistically significant increased %TBWL with aspiration therapy compared to lifestyle modification at 12 months, 12.1% and 18.3% TBWL versus 3.5% and 5.9% TBWL with mean differences of 8.8% and 12.4% [32, 33].”
BackgroundMethodResultInfluentialEndoscopic bariatrics: current therapies and future directions
Reja, D., Zhang, C., & Sarkar, A. (2022) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2020.03.09 · Cited by 24
“The most common adverse events were peristomal granulation tissue, post-operative abdominal pain, irritation at the tube site, and nausea, but 99% of these events were considered mild to moderate and managed conservatively (38).”
BackgroundUpdates in endoscopic bariatric and metabolic therapies.
Qureshi, H., Saeed, N., & Jovani, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031126 · Cited by 21
“Serious adverse effects are rare, including peritonitis and prepyloric ulceration or tube removal [50].”
BackgroundRen, M., Zhou, X., Lv, L., & Ji, F. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00448 · Cited by 12
Rothstein, R. I., Kopjar, B., Woodman, G. E., Swain, J. M., de la Cruz-Muñoz, N., Kushnir, V. M., Pryor, A. D., English, W. J., Odstrcil, E. A., & Sullivan, S. (2024) · Techniques and Innovations in Gastrointestinal Endoscopy · doi:10.1016/j.tige.2023.10.002 · Cited by 11
Self-citation
Metadata
- Authors
- Thompson, C. C., Abu Dayyeh, B. K., Kushner, R., Sullivan, S., Schorr, A. B., Amaro, A., Apovian, C. M., Fullum, T., Zarrinpar, A., Jensen, M. D., Stein, A. C., Edmundowicz, S., Kahaleh, M., Ryou, M., Bohning, M. J., Ginsberg, G., Huang, C., Tran, D. D., Glaser, J. P., Martin, J. A., Jaffe, D. L., Farraye, F. A., Ho, S. B., Kumar, N., Harakal, D., Young, M., Thomas, C. E., Shukla, A. P., Ryan, M. B., Haas, M., Goldsmith, H., McCrea, J., & Aronne, L. J.
- Venue
- American Journal of Gastroenterology
- Published
- 2017-03
- Volume
- 112
- Issue
- 3
- Pages
- 447-457
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2560187051
- Cited by
- 201
- References
- 4
- FWCI
- 21.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.